Stryker Corporation ($SYK) Stock Forecast: Down 1.9% Today

What is Stryker Corporation?

Stryker Corporation (SYK) is a medical technology company that has recently experienced a bearish market movement.

Why is Stryker Corporation going down?

SYK stock is down 1.9% on Mar 6, 2026 15:56

• Pitcairn Co. reducing its stake in Stryker Corporation by 30.8% and Director Ronda E. Stryker selling a significant number of shares might have signaled concerns among investors, leading to a bearish sentiment.
• Despite positive news such as surpassing EPS expectations, revenue growth, and a quarterly dividend declaration, the significant sell-off by key stakeholders could have outweighed these positive factors.
• The muted market reaction to William Blair's Outperform rating and the lack of a new price target may have also contributed to the bearish movement as investors may have been expecting a more bullish outlook.
• The increase in stake by Dimensional Fund Advisors LP and other institutional investors contrasts with the significant insider selling, creating uncertainty and potentially adding to the downward pressure on the stock price.

SYK Price Chart

SYK Technical Analysis

SYK News

Pitcairn Co. Trims Stock Holdings in Stryker Corporation $SYK

Pitcairn Co. reduced its stake in Stryker Corporation (NYSE:SYK) by 30.8% in Q3, selling 3,018 shares and leaving 6,774 shares valued at $2.504 million. Simultaneously, Director Ronda E. Stryker sold 250,000 shares for approximately $90.73 million, decreasing her ownership by 9.23%. Despite these sales, Stryker recently surpassed EPS expectations and reported revenue growth, and it also declared a quarterly dividend.

https://www.marketbeat.com/instant-alerts/filing-pitcairn-co-trims-stock-holdings-in-stryker-corporation-syk-2026-03-06/

William Blair Maintains Outperform for Stryker Corporation (SYK) March 2026

William Blair has reiterated an Outperform rating for Stryker Corporation (SYK) on March 5, 2026, citing international expansion and M&A as key drivers for potential upside. Despite the positive outlook, the firm did not provide a new price target, and the market reaction was muted with a slight share price dip. Meyka AI rates SYK with an "A" grade, indicating a constructive medium-term view for investors based on various performance metrics.

https://meyka.com/blog/william-blair-maintains-outperform-for-stryker-corporation-syk-march-2026-0603/

Stryker Corporation $SYK Shares Purchased by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP increased its stake in Stryker Corporation (NYSE:SYK) by 12.0% in the third quarter, bringing its total holdings to 933,161 shares valued at $344.96 million. Other institutional investors like Vanguard Group Inc., State Street Corp, and Alliancebernstein L.P. also significantly increased their positions in the medical technology company. This news follows a director's sale of 250,000 shares and a recent quarterly dividend declaration by Stryker.

https://www.marketbeat.com/instant-alerts/filing-stryker-corporation-syk-shares-purchased-by-dimensional-fund-advisors-lp-2026-03-06/

Truist Financial Maintains Stryker Corp(SYK.US) With Hold Rating

Truist Financial analyst Richard Newitter has maintained a hold rating on Stryker Corp (SYK.US). Newitter has a reported success rate of 49.9% and an average return of 9.2% over the last year, according to TipRanks data. This rating is for informational purposes and not an investment recommendation.

https://news.futunn.com/en/post/69665690/truist-financial-maintains-stryker-corp-sykus-with-hold-rating

Snyder Capital Management L P Has $60.48 Million Holdings in Mercury Systems Inc $MRCY

Snyder Capital Management L.P. significantly reduced its stake in Mercury Systems Inc. by 18.4% in the third quarter, now holding 781,404 shares valued at $60.48 million. Despite institutional ownership remaining high at nearly 96%, insiders have been net sellers, divesting over $74 million in shares within the last 90 days. While Mercury Systems beat quarterly earnings and revenue estimates, it still reported a negative net margin, and analysts largely rate the stock as a "Hold" with an average target price of $86.89.

https://www.marketbeat.com/instant-alerts/filing-snyder-capital-management-l-p-has-6048-million-holdings-in-mercury-systems-inc-mrcy-2026-03-05/

Trending Today

Brent Crude Oil ($BRENT) Commodity Forecast: Down 5.3% Today

Crude Oil ($CRUDE) Commodity Forecast: Down 5.5% Today

Astera Labs Inc ($ALAB) Stock Forecast: Down 5.0% Today

Corning Incorporated ($GLW) Stock Forecast: Up 5.2% Today

Power Integrations Inc. ($POWI) Stock Forecast: Down 6.3% Today

GitLab Inc. ($GTLB) Stock Forecast: Down 5.3% Today

IPG Photonics Corporation ($IPGP) Stock Forecast: Down 5.3% Today

Expedia Group Inc. ($EXPE) Stock Forecast: Down 5.6% Today

United Rentals Inc. ($URI) Stock Forecast: Down 6.1% Today

Upwork Inc. ($UPWK) Stock Forecast: Down 5.2% Today

Stryker Corporation Price History

01.07.2025 - SYK Stock was down 5.3%

• Despite surpassing earnings and revenue projections in Q2, Stryker (SYK) witnessed a downturn in its stock performance.
• Concerns regarding increased costs and tariffs potentially impacted margins, influencing market sentiment negatively.
• Comparisons made by investors between Stryker (SYK) and peers like SNN might have contributed to the bearish trend.
• Although Stryker (SYK) has demonstrated strong long-term growth over the last two decades, short-term apprehensions may have outweighed this performance, leading to the recent market decline.

07.02.2025 - SYK Stock was down 5.7%

• Despite recent product launches like Steri-Shield 8 and Sync Badge, SYK stock observed a bearish trend today.
• The market response could be attributed to broader market conditions or profit-taking following a period of considerable outperformance.
• Investor sentiments may be influenced by potential challenges in the healthcare field, such as regulatory modifications or competitive pressures impacting SYK's future growth.
• It is noteworthy that short-term stock fluctuations may not consistently mirror the enduring value and potential of a company like Stryker, known for providing substantial returns to investors across the years.

04.01.2026 - SYK Stock was up 0.3%

• The bullish movement in SYK stock can be attributed to the company's announcement of a 4.8% increase in its quarterly dividend, showcasing financial strength and investor confidence.
• Institutional bullish sentiment towards the stock is evident with Jones Financial Companies Lllp increasing its stake in Stryker Corporation by 20.8% despite insider selling.
• Stryker's strong quarterly earnings, beating expectations with an 11.4% year-over-year revenue increase, have likely contributed to the positive market movement.
• Overall, the market seems to be reacting positively to Stryker's robust financial performance and strategic decisions, setting a bullish tone for the stock's future outlook.

02.04.2025 - SYK Stock was up 0.4%

• SYK exceeded Q1 earnings and revenue estimates, showcasing strong financial performance and exceeding market expectations.
• The company's consistent outperformance over the past decade has attracted investor interest, leading to a bullish movement in the stock.
• Expectations of strong segmental performance in Q1 further fueled investor confidence in SYK's growth prospects.
• The comparison with other companies like AHCO and ISRG highlights SYK's position as a valuable stock in the medical technology industry, contributing to its bullish market movement.

10.03.2025 - SYK Stock was down 5.5%

• Possible reasons for the decline in SYK stock today:
• Investors favoring PBH, a competitor in the same sector, over SYK due to perceived differences in value.
• Worries regarding SYK's growth outlook or financial results relative to its industry peers.
• Market instability and general economic conditions affecting overall investor trust in the healthcare products industry.

06.00.2026 - SYK Stock was up 5.1%

• Stryker's bullish movement today could be attributed to multiple factors:
• The appointment of Scott Sacha as Vice President of Enterprise Data Services, signaling the company's commitment to enhancing data-driven strategies for improving patient outcomes globally.
• The initiation of coverage by Raymond James with a 'buy' rating and a target price of $418, indicating positive sentiment and potential growth prospects for the company.
• The acquisition of Stryker's spine implant manufacturing facility by VB Spine LLC, expanding global manufacturing capabilities and strategic footprint, seen as a positive move for Stryker's overall business outlook.
• Overall, these developments highlight Stryker's efforts to strengthen its position in the medical technology industry through strategic partnerships, data-driven initiatives, and favorable analyst ratings, contributing to the bullish market movement of the stock today.

23.06.2025 - SYK Stock was up 1.2%

• SYK's strong bullish movement today could be attributed to its consistent outperformance in the market over the past decade, with an impressive average annual return of 14.76%.
• The comparison between Intuitive Surgical and Stryker in the robotic surgery sector might have sparked investor interest in SYK, highlighting its potential as a strong investment opportunity.
• The news of Representative Thomas Kean selling a portion of Stryker stock may have initially caused some uncertainty, but the market quickly rebounded, showcasing confidence in the company's long-term growth prospects.
• Overall, SYK's bullish trend today reflects investor confidence in the company's leadership in orthopedic surgeries and its ability to deliver consistent returns, despite minor fluctuations in stock transactions.

17.06.2024 - SYK Stock was up 3.5%

• Stryker (SYK) recently finalized the acquisition of Artelon, a strategic move to strengthen its position in the soft tissue fixation market. This acquisition has likely bolstered investor confidence in the company's growth trajectory.
• A comparative analysis of EYE and SYK in terms of value might have also attracted increased attention to Stryker's stock, with investors scouting for robust investment prospects in the healthcare sector.
• In essence, Stryker's positive market performance today can be linked to the encouraging updates regarding the acquisition and its perceived value proposition relative to other market stocks.

08.11.2025 - SYK Stock was down 1.7%

• The bearish movement in SYK's stock today could be attributed to the significant insider selling observed recently, with insiders offloading a substantial number of shares worth millions of dollars. This selling pressure might have raised concerns among investors about the company's future performance.
• Despite the insider selling, institutional investors like Natixis have shown confidence in Stryker by increasing their stake, indicating a positive outlook for the company.
• The recent promotion of a new president and COO to lead the M&A strategy could signal potential changes in the company's direction, which might have caused uncertainty among investors and contributed to the bearish market movement.
• While Stryker has been making strategic acquisitions and reporting strong financial results, the mixed signals from insider selling and institutional buying could have created a sense of ambiguity in the market, leading to the bearish trend in SYK's stock today.

30.00.2026 - SYK Stock was up 2.8%

• Stryker (SYK) experienced a strong bullish movement today following a series of positive events and analyst actions.
• Resmed's strong Q2 results and increased CPAP demand in the healthcare sector likely boosted investor confidence in medical device companies, including Stryker.
• Analyst upgrades from Needham, Canaccord Genuity, and BTIG, along with institutional investments from Mirae Asset Global Investments Co. Ltd., contributed to the positive sentiment surrounding Stryker's stock.
• The market's reaction indicates that investors are optimistic about Stryker's future growth prospects, solid financial performance, and continued innovation in the medical technology space.

19.07.2025 - SYK Stock was up 1.2%

• Stryker (SYK) has outperformed the market over the past 10 years, showcasing consistent growth and strong performance.
• The comparison between Stryker (SYK) and Smith & Nephew (SNN) might have sparked investor interest, with Stryker being perceived as a more attractive option.
• The positive long-term performance of Stryker (SYK) could have contributed to today's bullish movement, as investors continue to see value in the company's stock.

06.02.2026 - SYK Stock was down 1.9%

• Pitcairn Co. reducing its stake in Stryker Corporation by 30.8% and Director Ronda E. Stryker selling a significant number of shares might have signaled concerns among investors, leading to a bearish sentiment.
• Despite positive news such as surpassing EPS expectations, revenue growth, and a quarterly dividend declaration, the significant sell-off by key stakeholders could have outweighed these positive factors.
• The muted market reaction to William Blair's Outperform rating and the lack of a new price target may have also contributed to the bearish movement as investors may have been expecting a more bullish outlook.
• The increase in stake by Dimensional Fund Advisors LP and other institutional investors contrasts with the significant insider selling, creating uncertainty and potentially adding to the downward pressure on the stock price.